{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T03:32:40Z","timestamp":1772767960460,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"PAPES\/Fiocruz"},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004586","name":"Faperj","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.ejmech.2017.01.007","type":"journal-article","created":{"date-parts":[[2017,1,6]],"date-time":"2017-01-06T16:16:12Z","timestamp":1483719372000},"page":"434-441","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["N -(2-(arylmethylimino)ethyl)-7-chloroquinolin-4-amine derivatives, synthesized by thermal and ultrasonic means, are endowed with anti-Zika virus activity"],"prefix":"10.1016","volume":"127","author":[{"given":"Giselle","family":"Barbosa-Lima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ligia S.","family":"da Silveira Pinto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos R.","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James L.","family":"Wardell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline S.","family":"De Freitas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasmine R.","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andressa","family":"Marttorelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Cerbino Neto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patr\u00edcia T.","family":"Bozza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Solange M.S.V.","family":"Wardell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcus V.N.","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thiago M.L.","family":"Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2017.01.007_bib1","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.bmcl.2005.10.033","article-title":"Antimalarial activity of 4-(5-trifluoromethyl-1h-pyrazol-1-yl)-chloroquine analogues","volume":"16","author":"Cunico","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.01.007_bib2","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ejphar.2006.11.061","article-title":"Enhanced activity of mefloquine and artesunic acid against plasmodium falciparum in\u00a0vitro and p. berghei in mice by combination with ciprofloxacin","volume":"558","author":"Andrade","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2017.01.007_bib3","doi-asserted-by":"crossref","first-page":"3868","DOI":"10.1128\/AAC.00510-08","article-title":"Synthesis, antimalarial activity, and intracellular targets of mefas, a new hybrid compound derived from mefloquine and artesunate","volume":"52","author":"de P. Varotti","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2017.01.007_bib4","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1016\/j.bmc.2009.01.013","article-title":"Synthesis and in\u00a0vitro antitubercular activity of a series of quinoline derivatives","volume":"17","author":"de Souza","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.01.007_bib5","doi-asserted-by":"crossref","first-page":"6095","DOI":"10.1016\/j.ejmech.2010.09.024","article-title":"Synthesis and antitubercular activity of new mefloquine-oxazolidine derivatives","volume":"45","author":"Gon\u00e7alves","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.01.007_bib6","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1007\/s00706-015-1570-0","article-title":"A\u00a0new and potent class of quinoline derivatives against cancer","volume":"146","author":"de L.F. Bispo","year":"2015","journal-title":"Monatsh. Chem."},{"key":"10.1016\/j.ejmech.2017.01.007_bib7","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1002\/jhet.2212","article-title":"Synthesis of novel ethyl (substituted)phenyl-4-oxothiazolidin-3-yl)-1-ethyl-4-oxo-1,4-dihydroquinoline-3-carboxylates as potential anticancer agents","volume":"52","author":"Facchinetti","year":"2015","journal-title":"J.\u00a0Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2017.01.007_bib8","doi-asserted-by":"crossref","first-page":"599","DOI":"10.2174\/157340611797928299","article-title":"Synthesis and antitumoral evaluation of 7-chloro-4-quinolinylhydrazones derivatives","volume":"7","author":"Montenegro","year":"2011","journal-title":"Med. Chem."},{"key":"10.1016\/j.ejmech.2017.01.007_bib9","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2174\/157018012799129837","article-title":"Cytotoxic activity of polysubstituted 7-chloro-4-quinolinylhydrazone derivatives","volume":"9","author":"Montenegro","year":"2012","journal-title":"Lett. Drug Des. Discov."},{"key":"10.1016\/j.ejmech.2017.01.007_bib10","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.bmcl.2013.12.074","article-title":"Design, synthesis and biological evaluation of (e)-2-(2-arylhydrazinyl)quinoxalines, a promising and potent new class of anticancer agents","volume":"24","author":"Rodrigues","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.01.007_bib11","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/cbdd.12210","article-title":"Mefloquine-Oxazolidine derivatives: a new class of anticancer agents","volume":"83","author":"Rodrigues","year":"2014","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2017.01.007_bib12","article-title":"Chloroquine inhibits zika virus infection in different cellular models","author":"Delvecchio","year":"2016","journal-title":"Cold Spring Harb. Labs Journals"},{"key":"10.1016\/j.ejmech.2017.01.007_bib13","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1128\/CMR.00072-15","article-title":"Zika virus","volume":"29","author":"Musso","year":"2016","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ejmech.2017.01.007_bib14","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3201\/eid2102.141363","article-title":"Potential sexual transmission of zika virus","volume":"21","author":"Musso","year":"2015","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.ejmech.2017.01.007_bib15","doi-asserted-by":"crossref","first-page":"372","DOI":"10.15585\/mmwr.mm6514a3","article-title":"Male-to-male sexual transmission of zika virus","volume":"65","author":"Deckard","year":"2016","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.ejmech.2017.01.007_bib16","first-page":"2195","article-title":"Evidence of sexual transmission of zika virus. N. Engl","volume":"374","author":"D'Ortenzio","year":"2016","journal-title":"J.\u00a0Med."},{"key":"10.1016\/j.ejmech.2017.01.007_bib17","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.3201\/eid1408.080287","article-title":"Genetic and serologic properties of zika virus associated with an epidemic","volume":"14","author":"Lanciotti","year":"2008","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.ejmech.2017.01.007_bib18","unstructured":"WHO. WHO report| Zika Situation Report."},{"key":"10.1016\/j.ejmech.2017.01.007_bib19","unstructured":"WHO. WHO report| WHO Director-general Summarizes the Outcome of the Emergency Committee Regarding Clusters of Microcephaly and Guillain-barr\u00e9 Syndrome http:\/\/www.who.int\/mediacentre\/news\/statements\/2016\/emergency-committee-zika-microcephaly\/en\/(Accessed 30 August 2016)."},{"key":"10.1016\/j.ejmech.2017.01.007_bib20","article-title":"The clinically approved antiviral drug sofosbuvir impairs brazilian zika virus replication","author":"Sacramento","year":"2016","journal-title":"Cold Spring Harb. Labs Journals"},{"key":"10.1016\/j.ejmech.2017.01.007_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.celrep.2016.08.038","article-title":"Zika virus disrupts phospho-tbk1 localization and mitosis in human neuroepithelial stem cells and radial glia","volume":"16","author":"Onorati","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejmech.2017.01.007_bib22","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.chom.2016.07.004","article-title":"A\u00a0screen of fda-approved drugs for inhibitors of zika virus infection","volume":"20","author":"Barrows","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ejmech.2017.01.007_bib23","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nm.4184","article-title":"Identification of small-molecule inhibitors of zika virus infection and induced neural cell death via a drug repurposing Screen","volume":"22","author":"Xu","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejmech.2017.01.007_bib24","unstructured":"E.P. Acosta, C. Flexner, Antiviral agents (nonretroviral), in: Goodman & Gilman's - the Pharmacological Basis of Therapeutics, New York, 2011, pp. 1593\u20131622."},{"key":"10.1016\/j.ejmech.2017.01.007_bib25","unstructured":"C. Flexner, Antiretroviral agents and treatment of HIV infection, in: Goodman and Gilman's - the Pharmacological Basis of Therapeutics, New York, 2011, pp. 1623\u20131664."},{"key":"10.1016\/j.ejmech.2017.01.007_bib26","unstructured":"Data were collected at 100(2)K with Mo-Ka radiation using an Rigaku Saturn724+ (2x2 bin mode) of the UK National Crystallographic Service (NCS), based at the University of Southampton. Data collection, data reduction and unit cell refinement were achieved with CrystalClear-SM Expert 3.1 b27. Correction for absorption was achieved by an empirical absorption correction using spherical harmonics, implemented in SCALE3 ABSPACK scaling algorithm. The program MERCURY were used in the preparation of the Figures. SHELXL97 and PLATON were used in the calculation of molecular geometry. The structures were solved by direct methods using SHELXS-97 and fully refined by means of the program SHELXL-97. Difference map peaks provided positions for water hydrogens and hydrogen attached to N(2). The coordinates, along with isotropic displacement parameters, were fully refined. All other hydrogen atoms were placed Calc. positions."},{"key":"10.1016\/j.ejmech.2017.01.007_bib27a","series-title":"CrystalClear-SM Expert","year":"2012"},{"key":"10.1016\/j.ejmech.2017.01.007_bib27b","unstructured":"Mercury 3.3.1 Cambridge Crystallographic Data Centre, UK,"},{"key":"10.1016\/j.ejmech.2017.01.007_bib27c","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1107\/S0108767307043930","article-title":"A\u00a0short history of SHELX","volume":"A64","author":"Sheldrick","year":"2008","journal-title":"Acta Crystallogr."},{"key":"10.1016\/j.ejmech.2017.01.007_bib27d","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1107\/S0021889802022112","article-title":"Single-Crystal structure validation with the program PLATON","volume":"36","author":"Spek","year":"2003","journal-title":"Appl. Crystallogr."},{"key":"10.1016\/j.ejmech.2017.01.007_bib28","unstructured":"Crystal data collected at 100(2)K; Colourless crystal: 0.11\u00a0\u00d7 0.08\u00a0\u00d7 0.05 mm; Formula: C19H24ClN3O4; M= 393.86; triclinic, P-1; a\u00a0= 7.0634(14) \u00c5, \u03b1\u00a0= 99.875(3)\u00b0, b\u00a0= 10.946(2) \u00c5, \u03b2\u00a0= 96.638(4)\u00b0, c\u00a0= 12.855(3) \u00c5, \u03b3\u00a0= 93.435(3)\u00b0, Z\u00a0= 2, V= 969.4(3)\u00c53; 4411 independent reflections [R(int)\u00a0= 0.0356]; 3827 observed reflections [I>2 s (I)]; data\/restrainsts\/parameters 4411\/0\/266; R1\u00a0= 0.035; largest diff. peak and hole 0.31 and -0.22 e.\u00c5-3. Atomic coordinates, bond lengths, angles and thermal parameters have been deposited at the Cambridge Crystallographic Data Centre, deposition number 1459439."},{"key":"10.1016\/j.ejmech.2017.01.007_bib29","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","article-title":"A\u00a0simple method of estimating fifty per cent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.ejmech.2017.01.007_bib30","first-page":"4827","article-title":"Evaluation of a soluble tetrazolium\/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines","volume":"48","author":"Scudiero","year":"1988","journal-title":"Cancer Res."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523417300077?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523417300077?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T03:55:39Z","timestamp":1536119739000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523417300077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":33,"alternative-id":["S0223523417300077"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2017.01.007","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"N-(2-(arylmethylimino)ethyl)-7-chloroquinolin-4-amine derivatives, synthesized by thermal and ultrasonic means, are endowed with anti-Zika virus activity","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2017.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}